Amgen executives and employees, local and state elected dignitaries, and an assortment of other local economic development ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The company says they will create hundreds of new jobs between 2028 and 2032, and the average pay will be more than $91,000 a year.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Amgen (Nasdaq: AMGN) has completed construction of a $550 million drug manufacturing facility in the Wake County town.

AstraZeneca invests $570 million in Canada, expands facilities, and boosts R&D efforts, aiming to deliver 20 new medicines ...

Reliever Tanner Scott’s $72 million, four-year contract with the Los Angeles Dodgers includes $21 million in deferred ...

Andrew Young is an influential leader in the biotechnology sector, serving as the CEO and Managing Partner of Conjugate Group ...

Scientists nationwide said the cancellation of NIH grant reviews has thrown early-career scientists into limbo ...

SEOUL, Jan. 24 (Korea Bizwire) — The South Korean government has announced an ambitious initiative to position the country as ...

A major downgrade, a billion-dollar pipeline gamble, and a patent war--Exelixis investors brace for a wild ride.

FibroBiologics, Inc., a pharmaceutical company based in Houston, Texas, has disclosed the approval of annual incentive bonuses for its top executives following a recent board meeting. The decision, ...